溢价近50%，超4亿元资金追捧这只医药股

Market Overview - A total of 83 stocks hit the daily limit up in the A-share market, with 65 stocks hitting the limit after excluding 18 ST stocks, resulting in an overall limit-up rate of 84.69% [1] Top Performers - Asia-Pacific Pharmaceutical had the highest limit-up order volume, exceeding 400 million yuan, with a total of 674,900 hands [2] - ST Dongyi achieved 7 consecutive limit-ups, while ST Erya and others had multiple consecutive limit-ups, indicating strong market interest [2] Industry Highlights Robotics - Companies such as Yuanda Intelligent and Zhongjian Technology saw limit-ups, with Yuanda Intelligent focusing on industrial and intelligent robots [3][4] - Zhongjian Technology is in the early investment phase in the AI robotics sector, while Sifang Co. is exploring applications of robots in operations and services [4] Pharmaceuticals - Companies like Anglikang and Lianhuan Pharmaceutical also hit limit-ups, with Anglikang focusing on innovative drug development and Lianhuan targeting metabolic and respiratory diseases [5] - Jimin Health's DB006 oncolytic adenovirus injection has received clinical trial approval, marking a significant step in its drug development pipeline [5] Photovoltaics - Guosheng Technology and Shuangliang Energy both achieved limit-ups, with Guosheng focusing on EPC projects for photovoltaic power stations [6][7] - Shuangliang Energy's customized liquid cooling system solutions have gained recognition in a major energy storage project in Qinghai [6] Institutional Activity - Jinpan Technology saw nearly 200 million yuan in net purchases from institutions, indicating strong institutional interest in the stock [8] - Other stocks like Sanhua Intelligent and Xiangrikui also featured prominently in institutional net buying, reflecting a trend of investment in high-potential sectors [8]